Literature DB >> 383283

5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.

J L Au, W Sadée.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383283

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.

Authors:  S Kawata; S Noda; Y Imai; S Tamura; R Saitoh; S Miyoshi; Y Minami; S Tarui
Journal:  Gastroenterol Jpn       Date:  1987-02

2.  Changes in toxic and antitumor properties of ftorafur by induction or inhibition of the microsomal enzymes activity.

Authors:  G A Belitsky; V M Bukhman; I A Konopleva
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Effects of 5-Fluorouracil prodrugs on the central nervous system in mice and rats.

Authors:  K Toide; N Unemi; T Segawa
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

4.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.